22nd Century Group Inc/ US90137F3010 /
9/19/2024 9:59:50 PM | Chg. +0.02 | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
0.26USD | +6.98% | 4,894 Turnover: 1,274.57 |
-Bid Size: - | -Ask Size: - | 0.27 | 0.24 |
GlobeNewswire
11/8/2023
22nd Century Group Continues VLN® Expansion, Now Retailing in More Than 5,100 Stores
GlobeNewswire
11/7/2023
22nd Century Group (XXII) Expands Reduced Nicotine Content Tobacco IP with Latest Technology License
GlobeNewswire
10/26/2023
22nd Century Group (XXII) Supports FDA Policy Advancements, Proposed Menthol Ban Now at OMB
GlobeNewswire
9/12/2023
22nd Century Group (XXII) Adds 1,200 Drug Store Locations Selling VLN® in Five States
GlobeNewswire
9/5/2023
22nd Century Group Initiates Strategic Alternatives Process for Its Tobacco Assets
GlobeNewswire
9/5/2023
Presenting on the Emerging Growth Conference on September 6 and 7 Register Now
GlobeNewswire
3/28/2022
FDA Authorized Reduced-Nicotine Cigarette from 22nd Century Group (Nasdaq: XXII) That ‘Helps You Smo...
GlobeNewswire
3/9/2022
22nd Century Group (Nasdaq: XXII) to Host Investor Meetings at Roth Capital Conference March 14-15
GlobeNewswire
2/25/2022
22nd Century Group Welcomes Dr. Califf as FDA Commissioner, Urges Action on Menthol and Nicotine in ...
GlobeNewswire
2/3/2022
22nd Century Group to Announce Fourth Quarter and Full Year 2021 Results on March 1, 2022
GlobeNewswire
1/26/2022
22nd Century Group Announces First Production of VLN® Cigarettes for Retail Sale